FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma, Inc.'s supplemental application for Vigabatrin (ANDA 209822).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)